Edgewise Therapeutics Statistics
Total Valuation
EWTX has a market cap or net worth of $3.20 billion. The enterprise value is $2.75 billion.
Important Dates
The last earnings date was Thursday, February 26, 2026, before market open.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
EWTX has 107.27 million shares outstanding. The number of shares has increased by 11.38% in one year.
| Current Share Class | 107.27M |
| Shares Outstanding | 107.27M |
| Shares Change (YoY) | +11.38% |
| Shares Change (QoQ) | +0.49% |
| Owned by Insiders (%) | 0.56% |
| Owned by Institutions (%) | 78.94% |
| Float | 67.60M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 6.30 |
| P/TBV Ratio | 6.28 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.85, with a Debt / Equity ratio of 0.01.
| Current Ratio | 19.85 |
| Quick Ratio | 19.37 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -34.19% and return on invested capital (ROIC) is -24.16%.
| Return on Equity (ROE) | -34.19% |
| Return on Assets (ROA) | -23.02% |
| Return on Invested Capital (ROIC) | -24.16% |
| Return on Capital Employed (ROCE) | -36.44% |
| Weighted Average Cost of Capital (WACC) | 5.70% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.15M |
| Employee Count | 146 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +9.27% in the last 52 weeks. The beta is 0.27, so EWTX's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +9.27% |
| 50-Day Moving Average | 28.26 |
| 200-Day Moving Average | 19.53 |
| Relative Strength Index (RSI) | 53.83 |
| Average Volume (20 Days) | 899,773 |
Short Selling Information
The latest short interest is 9.49 million, so 8.85% of the outstanding shares have been sold short.
| Short Interest | 9.49M |
| Short Previous Month | 9.49M |
| Short % of Shares Out | 8.85% |
| Short % of Float | 14.04% |
| Short Ratio (days to cover) | 8.61 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -191.41M |
| Pretax Income | -167.80M |
| Net Income | -167.80M |
| EBITDA | -189.32M |
| EBIT | -191.41M |
| Earnings Per Share (EPS) | -$1.63 |
Full Income Statement Balance Sheet
The company has $530.11 million in cash and $3.99 million in debt, with a net cash position of $526.12 million or $4.90 per share.
| Cash & Cash Equivalents | 530.11M |
| Total Debt | 3.99M |
| Net Cash | 526.12M |
| Net Cash Per Share | $4.90 |
| Equity (Book Value) | 522.26M |
| Book Value Per Share | 4.92 |
| Working Capital | 516.02M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$143.82 million and capital expenditures -$256,000, giving a free cash flow of -$144.07 million.
| Operating Cash Flow | -143.82M |
| Capital Expenditures | -256,000 |
| Free Cash Flow | -144.07M |
| FCF Per Share | -$1.34 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
EWTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.38% |
| Shareholder Yield | -11.38% |
| Earnings Yield | -5.12% |
| FCF Yield | -4.39% |
Analyst Forecast
The average price target for EWTX is $36.00, which is 20.72% higher than the current price. The consensus rating is "Buy".
| Price Target | $36.00 |
| Price Target Difference | 20.72% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |